Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (12)

2024

  1. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

2023

  1. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

2022

  1. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

  2. Role and Diagnostic Performance of Host Epigenome in Respiratory Morbidity after RSV Infection: The EPIRESVi Study

    Frontiers in Immunology, Vol. 13

2020

  1. Altered pathways in methylome and transcriptome longitudinal analysis of normal weight and bariatric surgery women

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. DNA methylation screening after roux-en y gastric bypass reveals the epigenetic signature stems from genes related to the surgery per se

    BMC Medical Genomics, Vol. 12, Núm. 1

  2. Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis

    International Journal of Obesity, Vol. 43, Núm. 1, pp. 176-188

2017

  1. DNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern: A genome-wide analysis from non-obese and obese patients

    Scientific Reports, Vol. 7

2016

  1. DNA Methylation in Obesity and Associated Diseases

    Epigenetic Biomarkers and Diagnostics (Elsevier Inc.), pp. 313-329

  2. Genome-wide DNA methylation pattern in visceral adipose tissue differentiates insulin-resistant from insulin-sensitive obese subjects

    Translational Research, Vol. 178, pp. 13-24.e5

2015

  1. Notch1 pathway activation results from the epigenetic abrogation of notch-related MicroRNAs in mycosis fungoides

    Journal of Investigative Dermatology, Vol. 135, Núm. 12, pp. 3144-3152

2014

  1. Pre-treatment circulating leptin/ghrelin ratio as a non-invasive marker to identify patients likely to regain the lost weight after an energy restriction treatment

    Journal of Endocrinological Investigation, Vol. 37, Núm. 2, pp. 119-126